Clinical trials
Diabetes Mellitus, Type 2 trials in Vietnam
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 5 |
| Terminated | 4 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 11 |
| Hanoi Medical University | 4 |
| Boehringer Ingelheim | 3 |
| Bayer | 2 |
| Centre of Clinical Pharmacology, Hanoi Medical University | 2 |
| National Geriatric Hospital | 2 |
| Novo Nordisk A/S | 2 |
| BIOTRONIK Asia Pacific Pte Ltd | 1 |
| Cho Ray Hospital | 1 |
| International Diabetes Institute, Australia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 36 |
| Diabetes Mellitus | 7 |
| Hypertension | 5 |
| Cardiovascular Diseases | 3 |
| Insulin Resistance | 3 |
| Coronary Artery Disease | 2 |
| Diabetic Nephropathies | 2 |
| Kidney Diseases | 2 |
| Angina Pectoris | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.